Article
IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study
Neuro-Oncology
(2022)
Disciplines
Publication Date
2022
Citation Information
Shayna Zelcer. "IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study" Neuro-Oncology (2022) Available at: http://works.bepress.com/shayna-zelcer/14/